Alpha Teknova, Inc.
TKNO- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001850902
No open-market purchases or sales by Alpha Teknova, Inc. insiders were filed in the last 90 days; 79 institutions reported holding it in 13F filings for Q2 2026, worth $51.7M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Alpha Teknova, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- +5 vs. Q2 2024
- Shares held
- 5.14M
- −679.2K (−11.7%) vs. Q2 2024
- Total value
- $24.9M
- +$16.9M (+211.8%) vs. Q2 2024
- New holders
- 11
- 11 more added
- Sold out
- 6
- 9 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TKNO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 79 | $51.7M |
| Q1 2026 | 78 | $22.1M |
| Q4 2025 | 70 | $26.6M |
| Q3 2025 | 67 | $45.9M |
| Q2 2025 | 68 | $37.6M |
| Q1 2025 | 65 | $32.0M |
| Q4 2024 | 47 | $53.2M |
| Q3 2024 | 32 | $24.9M |
| Q2 2024 | 28 | $8.03M |
| Q1 2024 | 31 | $15.6M |
| Q4 2023 | 31 | $21.0M |
| Q3 2023 | 28 | $14.5M |
| Q2 2023 | 31 | $12.0M |
| Q1 2023 | 44 | $16.3M |
| Q4 2022 | 47 | $30.2M |
| Q3 2022 | 54 | $21.3M |
| Q2 2022 | 52 | $58.1M |
| Q1 2022 | 51 | $95.3M |
| Q4 2021 | 52 | $146.3M |
| Q3 2021 | 52 | $178.0M |
| Q2 2021 | 50 | $153.4M |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Alpha Teknova, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Balyasny Asset Management LLC | 1,000,090 | $4.84M | 0.01% | −45,579−4.4% | Reduced |
| Millennium Management LLC | 737,215 | $3.57M | 0.00% | −1,109,185−60.1% | Reduced |
| Vanguard Group Inc | 560,860 | $2.71M | 0.00% | +7,379+1.3% | Added |
| Roubaix Capital, LLC | 416,416 | $2.02M | 1.11% | +416,416 | New |
| Schonfeld Strategic Advisors LLC | 366,400 | $1.77M | 0.01% | +325,573+797.4% | Added |
| Point72 Asset Management, L.P. | 306,427 | $1.48M | 0.01% | +306,427 | New |
| Conestoga Capital Advisors, LLC | 305,129 | $1.48M | 0.02% | −148,770−32.8% | Reduced |
| Parkman Healthcare Partners LLC | 251,026 | $1.21M | 0.16% | −45,626−15.4% | Reduced |
| Bank of America Corp | 217,381 | $1.05M | 0.00% | +1,005+0.5% | Added |
| Geode Capital Management, LLC | 188,173 | $911.1K | 0.00% | +36,914+24.4% | Added |
| Bridgeway Capital Management, LLC | 110,000 | $532.4K | 0.01% | +50,000+83.3% | Added |
| FourWorld Capital Management LLC | 95,000 | $459.8K | 0.43% | +43,973+86.2% | Added |
| Renaissance Technologies LLC | 86,000 | $416.2K | 0.00% | +86,000 | New |
| State Street Corp | 76,645 | $371.0K | 0.00% | +54,700+249.3% | Added |
| BlackRock, Inc. | 74,095 | $358.6K | 0.00% | +74,095 | New |
| Citigroup Inc | 45,055 | $218.1K | 0.00% | +44,771+15,764.4% | Added |
| Fielder Capital Group LLC | 41,849 | $202.5K | 0.07% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 36,581 | $177.1K | 0.00% | −30,960−45.8% | Reduced |
| Morgan Stanley | 35,984 | $174.2K | 0.00% | −8,766−19.6% | Reduced |
| Northern Trust Corp | 29,813 | $144.3K | 0.00% | −617−2.0% | Reduced |
| Squarepoint Ops LLC | 28,597 | $138.4K | 0.00% | +28,597 | New |
| Qube Research & Technologies Ltd | 24,148 | $116.9K | 0.00% | +24,121+89,337.0% | Added |
| Jefferies Financial Group Inc. | 22,400 | $108.4K | 0.00% | +22,400 | New |
| Dimensional Fund Advisors LP | 17,855 | $86.1K | 0.00% | −1,271−6.6% | Reduced |
| Marshall Wace, LLP | 16,216 | $78.5K | 0.00% | +16,216 | New |
| GWM Advisors LLC | 13,679 | $66.2K | 0.00% | +13,679 | New |
| Cubist Systematic Strategies, LLC | 13,327 | $64.5K | 0.00% | +13,327 | New |
| Citadel Advisors LLC | 10,382 | $50.2K | 0.00% | +270+2.7% | Added |
| Two Sigma Investments, LP | 10,359 | $50.1K | 0.00% | +10,359 | New |
| Point72 Asia (Singapore) Pte. Ltd. | 1,942 | $9.40K | 0.00% | +1,942 | New |
| JPMorgan Chase & Co | 609 | $2.95K | 0.00% | +526+633.7% | Added |
| UBS Group AG | 451 | $2.18K | 0.00% | −5,831−92.8% | Reduced |
| Platinum Investment Management Ltd | 0 | $0 | 0.00% | −531,414−100.0% | Sold out |
| Osterweis Capital Management Inc | 0 | $0 | 0.00% | −155,170−100.0% | Sold out |
| Redmile Group, LLC | 0 | $0 | 0.00% | −154,509−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −12,003−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −8,075−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −123−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |